News

Pharmabiz6h
Zydus Medtech & Braile Biomedica of Brazil enter global licensing pact to commercialise TAVI technology
Zydus Medtech & Braile Biomedica of Brazil enter global licensing pact to commercialise TAVI technology: Our Bureau, Mumbai ...
Pharmabiz3h
INmune Bio to receive US patent for next-generation mesenchymal stromal cell product, CORDStrom
INmune Bio to receive US patent for next-generation mesenchymal stromal cell product, CORDStrom: Boca Raton, Florida Saturday, April 19, 2025, 17:00 Hrs [IST] INmune Bio Inc., a c ...
Pharmabiz4h
Chime Biologics and Polpharma Biologics partner to advance biosimilar development
Chime Biologics, a leading global CDMO that enables its partners’ success in biologics, announced a strategic cooperation agreement with Polpharma Biologics to advance the end-to-end development and ...
Pharmabiz5h
Cullinan Therapeutics gets EMA approval to begin phase 1 trial of CLN-978, a bispecific CD19 T cell engager administered RA
Cambridge, Massachusetts Saturday, April 19, 2025, 15:00 Hrs [IST] ...
Pharmabiz7h
GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices
GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices: London, UK Saturday, April 19, 2025, 13:00 Hrs ...
Pharmabiz6h
Lupin’s injectable facility in Nagpur receives EIR from US FDA
Lupin’s injectable facility in Nagpur receives EIR from US FDA: Our Bureau, Mumbai Saturday, April 19, 2025, 13:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced ...
Pharmabiz6h
Autonomix Medical receives European patent for proprietary catheter-based technology
Autonomix Medical receives European patent for proprietary catheter-based technology: The Woodlands, Texas Saturday, April 19, 2025, 14:00 Hrs [IST] Autonomix Medical, Inc., a med ...
Pharmabiz10h
ACIP votes to expand recommendation for Pfizer’s RSV vaccine Abrysvo to include adults aged 50 to 59 at increased risk of disease
the prevention of LRTD caused by RSV in people 18 through 59 years of age who are at increased risk for LRTD caused by RSV pregnant individuals at 32 through 36 weeks gestational age for the ...
Pharmabiz9h
IPA Karnataka State Branch and Adichunchanagiri University to hold 5 day online Career Conclave from Aril 21-25
IPA Karnataka State Branch and Adichunchanagiri University to hold 5 day online Career Conclave from Aril 21-25: Our Bureau, Bengaluru Saturday, April 19, 2025, 11:00 Hrs [IST] IP ...
Pharmabiz11h
US Advisory Committee on Immunization Practices recommends approval of GSK’s RSV vaccines, Arexvy for adults aged 50-59
US Advisory Committee on Immunization Practices recommends approval of GSK’s RSV vaccines, Arexvy for adults aged 50-59: London, UK Saturday, April 19, 2025, 09:00 Hrs [IST] GSK ...
Pharmabiz12h
Bavarian State Govt to give fillip to Karnataka life science cos by infusing expertise in technology
Nandita Vijayasimha, Bengaluru Saturday, April 19, 2025, 08:00 Hrs [IST] ...
Pharmabiz8h
Illumina & Tempus collaborate to drive future of precision medicine through genomic AI innovation
Illumina & Tempus collaborate to drive future of precision medicine through genomic AI innovation: San Diego Saturday, April 19, 2025, 12:00 Hrs [IST] Illumina Inc. and Tempus AI, ...